תאריך רישום: June 7, 2004

מסלול הגשה: מולקולה חדשה

יצרן: MERCK S.L., SPAIN

בעל רישום: MERCK SERONO LTD

G03GA05 :ATC Code

4.1 Therapeutic indications In adult women • Anovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomiphene citrate. • Stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra-fallopian transfer (ZIFT). • GONAL-f in association with a luteinising hormone (LH) preparation is recommended for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/L In adult men • GONAL-f is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotropin (hCG) therapy. 

תאריך רישום: August 2, 2004

מסלול הגשה: מולקולה חדשה

יצרן: BIEFFE MEDITAL S.P.A, ITALY

בעל רישום: REMEDIX CARE LTD

B05XB03 :ATC Code

Therapeutic indications that is characterized by the shift of potassium, phosphorus, and magnesium Primene 10% is indicated in 1) children and infants 2) neonates, at term or premature, intracellularly as the patient becomes anabolic. Thiamine deficiency and fluid of normal or low birth weight when oral or enteral nutrition is impossible, insufficient or retention may also develop. Careful monitoring and slowly increasing nutrient intakes contraindicated. while avoiding overfeeding can prevent these complications.

תאריך רישום: September 1, 2009

מסלול הגשה: מולקולה חדשה

יצרן: MERCK SHARP & DOHME-CHIBRET, FRANCE

בעל רישום: RAFA LABORATORIES LTD

S01ED01 :ATC Code

4.1 Therapeutic indications Indicated for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension, open-angle glaucoma, or other secondary open-angle glaucoma when concomitant therapy is appropriate.

תאריך רישום: December 29, 2008

מסלול הגשה: מולקולה חדשה

יצרן: FAMAR S.A., GREECE

בעל רישום: HALEON CH ISRAEL LTD.

N07BA01 :ATC Code

4.1 Therapeutic indications As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms. In smokers currently unable or not ready to stop smoking abruptly the gum may also be used as part of a program to reduce smoking prior to stopping completely

תאריך רישום: December 30, 2009

מסלול הגשה: מולקולה חדשה

יצרן: FAMAR S.A., GREECE

בעל רישום: HALEON CH ISRAEL LTD.

N07BA01 :ATC Code

4.1 Therapeutic indications As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms. In smokers currently unable or not ready to stop smoking abruptly the gum may also be used as part of a program to reduce smoking prior to stopping completely

תאריך רישום: December 29, 2008

מסלול הגשה: מולקולה חדשה

יצרן: FAMAR S.A., GREECE

בעל רישום: HALEON CH ISRAEL LTD.

N07BA01 :ATC Code

4.1 Therapeutic indications As an aid to smoking cessation and for the relief of nicotine withdrawal symptoms. In smokers currently unable or not ready to stop smoking abruptly the gum may also be used as part of a program to reduce smoking prior to stopping completely